We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$247M
AUM Growth
+$26.9M
Cap. Flow
+$1.99M
Cap. Flow %
0.81%
Top 10 Hldgs %
28.64%
Holding
82
New
13
Increased
21
Reduced
29
Closed
19

Sector Composition

Rank Sector Weight
1 Healthcare 89.54%
2 Industrials 0.78%
3 Energy 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRX
76
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-347
Closed -$520K
HMSY
77
DELISTED
HMS Holdings Corp.
HMSY
-41,800
Closed -$788K
EVHC
78
DELISTED
Envision Healthcare Holdings Inc
EVHC
-41,750
Closed -$4.33M
TMH
79
DELISTED
Team Health Holdings Inc
TMH
-50,000
Closed -$2.9M
PCYC
80
DELISTED
PHARMACYCLICS INC
PCYC
-15,000
Closed -$1.76M
SKH
81
DELISTED
SKILLED HEALTHCARE GROUP, INC. CLASS A COM STK
SKH
-126,216
Closed -$833K
CBST
82
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
-25,000
Closed -$1.66M

Similar funds

Sivik Global Healthcare's Q4 2014 Portfolio in Review

As of Q4 2014, Sivik Global Healthcare held 82 positions worth $247M, up 12% from $220M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Sivik Global Healthcare's Q4 2014 filing shows 13 new, 21 increased, 29 reduced and 19 closed positions. Its largest new stake was Becton Dickinson: 40,693 shares worth $5.53M. The largest sale was Labcorp, an estimated $5.03M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 89% a quarter earlier, followed by Industrials and Energy.

  • Sivik Global Healthcare's largest Q4 2014 buy was Becton Dickinson: 40,693 shares worth $5.53M.
  • Sivik Global Healthcare added most to Celgene Corp in Q4 2014, an estimated $3.3M increase.
  • Sivik Global Healthcare's biggest Q4 2014 reduction was Cencora, cutting an estimated $3.44M.
  • Sivik Global Healthcare fully exited Labcorp in Q4 2014, selling an estimated $5.03M.
  • Sivik Global Healthcare's ten largest holdings make up 29% of its $247M portfolio in Q4 2014.
  • Sivik Global Healthcare opened 13 new positions and closed 19 in Q4 2014.
  • Sivik Global Healthcare's portfolio value rose 12% quarter-over-quarter to $247M.

Based on Sivik Global Healthcare's 13F filing for Q4 2014, filed 7 Jan 2015.